Molecular structure
Mechanism of action
KPV is a tripeptide derived from alpha-MSH studied for anti-inflammatory and gastrointestinal research. Third-party COA available with batch 2.
Research applications
This compound is supplied exclusively for in vitro and ex vivo research applications. Researchers are responsible for compliance with all applicable institutional, local, and national regulations governing the use of investigational compounds.
References
- [1]Third-party analytical test report available via COA download above.
- [2]Refer to primary literature for mechanism of action and pharmacokinetic data.
- [3]ClinicalTrials.gov — search compound name for registered studies.
- [4]PubMed — peer-reviewed publications indexed under compound name and CAS number.
Unit price
$129.00
Per 10mg vial
Research use only. This product is intended for laboratory research purposes only. Not for human consumption. Not a drug, food supplement, or cosmetic. Not evaluated by Health Canada or the FDA for therapeutic use. Misuse of research compounds may be illegal. The purchaser assumes full responsibility for compliance with all applicable regulations.
Related compounds
CJC-1295 no DAC + Ipamorelin 10mg
10mg vial
Growth hormone secretagogue blend.
BPC-157 10mg
10mg vial
Body protection compound for tissue and gut research.
TB-500 10mg
10mg vial
Thymosin Beta-4 fragment for healing research.
BPC + TB Blend 20mg
20mg vial
Combined healing blend: BPC-157 10mg + TB-500 10mg.